Author

T. Oliveira

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Microbiology· 2 Biochemistry· 1 Cancer Biology· 1 Zoology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 9 Research Focus:host-pathogen & immune response· 7 Assay:proteomics· 7 Organism:human· 6 Research Focus:cell type annotation· 5 Research Focus:benchmarking· 2 Research Focus:clustering· 2 Research Focus:differential expression· 2

Frequent Co-Authors

M. Caskey· 6 shared C. Gaebler· 5 shared V. Ramos· 5 shared A. Gazumyan· 4 shared M. C. Nussenzweig· 4 shared Z. Wang· 4 shared A. Cho· 3 shared F. Muecksch· 3 shared

Activity by Year

2020-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersImmunology

M. Caskey

Mutual co-authors in cluster

Author profile →

10 papers

Recent·Most cited

Tumor sialylation controls effective anti-cancer immunity in breast cancer

S. Mereiter, G. Jonsson, T. Oliveira, J. Helm, D. Hoffmann, M. Abeln, A.-K. Jochum, W. Jochum, M. J. Kellner, M. Feith, V. Tkalec, K. Wasilewska, J. Jiao, L. Emsenhuber, F. Holstein, , J. M. Penninger

This study shows that tumor sialylation suppresses anti-cancer immunity in breast cancer by altering immune cell interactions and checkpoint ligands, and that inhibiting sialylation enhances immune response and therapy effectiveness.

bioRxiv · Sep 20, 2023 · PreprintCancer Biology

Mast cell-derived BH4 is a critical mediator of postoperative pain

P. Starkl, G. Jonsson, T. J. Artner, B. L. Turnes, N. Serhan, T. Oliveira, L.-M. Gail, K. Stejskal, K. Channon, T. Kocher, G. Stary, V. Klang, N. Gaudenzio, S. Knapp, C. J. Woolf, , S. J. F. Cronin

This study identifies mast cell-derived BH4 as a key mediator of postoperative pain, showing that substance P triggers BH4-dependent serotonin release in mast cells, and blocking substance P reduces pain.

bioRxiv · Jan 24, 2023 · PreprintImmunology

Non-targeted isomer-sensitive N-glycome analysis reveals new layers of organ-specific diversity in mice.

J. Helm, S. Mereiter, T. Oliveira, A. Gattinger, D. M. Markovitz, J. M. Penninger, F. Altmann, J. Stadlmann

The paper presents a method for analyzing N-glycome diversity in mice tissues, revealing tissue-specific glycosylation patterns and non-canonical structures.

bioRxiv · Sep 19, 2022 · PreprintBiochemistry

Anti- SARS-CoV-2 Receptor Binding Domain Antibody Evolution after mRNA Vaccination

A. Cho, F. Muecksch, D. Schaefer-Babajew, Z. Wang, S. Finkin, C. Gaebler, V. Ramos, M. Cipolla, P. Mendoza, M. Agudelo, E. Bednarski, J. DaSilva, I. Shimeliovich, J. Dizon, M. Daga, , M. C. Nussenzweig

This study examines memory B cell evolution 5 months after mRNA vaccination in naive individuals, finding increased neutralizing activity but no further breadth or potency, and higher overall plasma neutralizing potency compared to natural infection.

bioRxiv · Jul 29, 2021Immunology

The contribution of the European LIFE program to mitigate damages caused by large carnivores in Europe

T. Oliveira, A. Treves, J. V. Lopez-Bao, M. Krofel

The paper reviews 135 LIFE projects to assess the effectiveness of methods for reducing damages caused by large carnivores, finding electric fences most effective but noting poor measurement standards.

bioRxiv · Jun 25, 2021Zoology

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies

F. Muecksch, Y. Weisblum, C. Barnes, F. Schmidt, D. Schaefer-Babajew, J. Lorenzi, A. Flyak, A. DeLaitsch, K. Huey-Tubman, S. Hou, C. Schiffer, C. Gaebler, Z. Wang, J. Da Silva, D. Poston, , P. Bieniasz

This study examines how somatic mutations in SARS-CoV-2 antibodies affect their neutralization potency, breadth, and resistance to escape mutations across six antibody lineages.

bioRxiv · Mar 7, 2021 · PreprintMicrobiology

Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA

C. Gaebler, S. D. Falcinelli, E. Stoffel, J. Read, R. Murtagh, T. Oliveira, V. Ramos, J. C. Lorenzi, J. L. Kirchherr, K. S. James, B. Allard, C. Baker, J. D. Kuruc, M. Caskey, N. Archin, , M. C. Nussenzweig

This study compares two novel assays, IPDA and Q4PCR, for measuring intact HIV proviral DNA in ART-suppressed individuals, finding significant differences in their frequency estimates.

bioRxiv · Oct 7, 2020Microbiology

Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals

D. F. Robbiani, C. Gaebler, F. Muecksch, J. Cetrulo Lorenzi, Z. Wang, A. Cho, M. Agudelo, C. Barnes, S. Finkin, T. Hagglof, T. Oliveira, C. Viant, A. Hurley, K. Millard, R. Kost, , Nuss

The paper analyzes antibody responses in convalescent individuals, finding low neutralizing titers but rare potent RBD-specific antibodies with broad antiviral potential.

bioRxiv · May 13, 2020Immunology

Public broadly neutralizing antibodies against hepatitis B virus in individuals with elite serologic activity

Q. Wang, E. Michailidis, Y. Yu, Z. Wang, A. M. Hurley, D. A. Oren, C. T. Mayer, A. Gazumyan, Z. Liu, Y. Zhou, T. Schoofs, K.-h. Yao, J. Nieke, J. Wu, Q. Jiang, , M. C. Nussenzweig

The paper identifies broadly neutralizing antibodies against HBV in elite neutralizers and shows that combinations of bNAbs targeting different epitopes are more effective than single bNAbs.

bioRxiv · Mar 4, 2020 · PreprintImmunology

Antigen responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir

P. Mendoza, J. R. Jackson, T. Oliveira, C. Gaebler, V. Ramos, M. Caskey, M. Jankovic, M. C. Nussenzweig, L. B. Cohn

The paper shows that antigen-responsive CD4+ T cell clones with latent HIV-1 proviruses persist in individuals, suggesting antigen exposure contributes to reservoir longevity.

bioRxiv · Jan 10, 2020Immunology